Lv2
110 积分 2023-04-10 加入
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
2个月前
已完结
Effect of early versus late or no tracheostomy on mortality and pneumonia of critically ill patients receiving mechanical ventilation: a systematic review and meta-analysis
2个月前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
3个月前
已完结
IL-5 and IL-5 receptor alpha polymorphisms are associated with atopic dermatitis in Koreans
3个月前
已完结
Comprehensive biomarker analysis of patients with idiopathic pulmonary fibrosis and interstitial lung disease with healthy individuals
3个月前
已完结
Biomarkers in Idiopathic Pulmonary Fibrosis
3个月前
已完结
Analytical method validation for biomarkers as a drug development tool: points to consider
4个月前
已完结
Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
4个月前
已完结
Suppression of Interleukin-1β-Induced Nitric Oxide Production in RINm5F Cells by Inhibition of Glucose-6-phosphate Dehydrogenase
4个月前
已完结
Characterization of -Asparaginase Fused with a Protective ScFv and the Protection Mechanism
4个月前
已完结
皖公网安备34019202002308
